Linking Temporal Patterns of Modifiable Behaviors to Weight Loss Outcomes

August 15, 2023 updated by: University of Colorado, Denver
This study is designed as an observational trial. The objective of this study is to follow-up with participants 3 years after completion of an 18-month comprehensive behavioral weight loss intervention. Outcomes of interest include change in body weight, body composition, physical activity, energy intake, and sleep. In addition, investigators will explore the associations between current physical activity, sleep, and energy intake patterns and body weight regulation.

Study Overview

Status

Enrolling by invitation

Detailed Description

A total of 170 participants were initially enrolled in the comprehensive behavioral weight loss intervention.In this study, investigators will conduct a follow-up visit 3 years after the completion of the intervention. Only participants who completed the behavioral weight loss intervention will be enrolled in this study. Participants will undergo testing of body weight, body composition, physical activity patterns, energy intake patterns, sleep patterns, resting metabolic rate, and total daily energy expenditure.

Study Type

Observational

Enrollment (Estimated)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Colorado
      • Aurora, Colorado, United States, 80045
        • University of Colorado Anschutz Medical Campus

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Participants previously enrolled in an 18-month behavioral weight loss intervention at the University of Colorado Anschutz Medical Campus. (NCT01985568)

Description

Inclusion Criteria:

  • Previous enrollment in standard behavioral weight loss intervention (NCT01985568 or NCT03411356)
  • Age 20-60 (This age range has been selected based upon the participants enrolled in the Parent Trial)
  • Capable and willing to give informed consent
  • Possess a smartphone to install and utilize the meal timing application
  • Capable and willing to wear the Actigraph, ActivPAL and Actiwatch-2 for 24 hours/day for 28 consecutive days
  • Willing to complete the Total Daily Energy Expenditure (TDEE) assessment which includes multiple urine collections and drinking stable water isotopes

Exclusion Criteria:

  • Being considered unsafe to participate as determined by the study physician (Dr. Catennaci)
  • New diagnosis of a medical condition (not observed in the Parent Trial) which may affect weight or energy metabolism (e.g. depression, CVD, diabetes, uncontrolled hypertension, untreated thyroid, renal, hepatic diseases)
  • Women who became pregnant after completing the Parent Trial
  • Current use or use within the last 6 months of prescription or over-the-counter medications known to affect appetite, weight, and sleep

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Participants from NCT01985568 or NCT03411356
All subjects who previously enrolled in the Parent Study's behavioral weight loss intervention (NCT01985568 or NCT03411356).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight Change
Time Frame: Baseline to 54 months
Change in body weight (kg)
Baseline to 54 months
Weight Maintenance
Time Frame: 18 months to 54 months
Change in body weight (kg)
18 months to 54 months
Fat Mass Change
Time Frame: Baseline to 54 months
Change in Fat Mass (kg)
Baseline to 54 months
Fat Free Mass Change
Time Frame: Baseline to 54 months
Change in Fat Free Mass (kg)
Baseline to 54 months
Fat Mass Maintenance
Time Frame: 18 months to 54 months
Change in Fat Mass (kg)
18 months to 54 months
Fat Free Mass Maintenance
Time Frame: 18 months to 54 months
Change in Fat Free Mass (kg)
18 months to 54 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Physical Activity Patterns
Time Frame: 0, 6, 12, 18, 24, 54 month
Physical activity patterns as measured by SenseWear armband (min/day)
0, 6, 12, 18, 24, 54 month
Physical Activity Patterns
Time Frame: 54 month
Physical activity patterns as measured by ActivPAL, Actigraph (min/day)
54 month
Change in Sleep
Time Frame: 0, 6, 12, 18, 24, 54 month
Sleep patterns as measured by SenseWear armband (h/day)
0, 6, 12, 18, 24, 54 month
Sleep Patterns
Time Frame: 54 month
Sleep patterns as measured by Actiwatch-2, ActivPAL, Actigraph (h/day)
54 month
Change in Energy Intake
Time Frame: 0, 6, 12, 18, 54 month
Energy Intake patterns as measured by 3 day food record (kcal/day
0, 6, 12, 18, 54 month
Energy Intake Patterns
Time Frame: 54 month
Energy Intake patterns as measured by 24 hour food recall and meallogger smartphone application (kcal/day)
54 month
Resting Metabolic Rate
Time Frame: 54 month
Resting metabolic rate as measured using indirect calorimetry (kcal/day)
54 month
Total Daily Energy Expenditure
Time Frame: 54 month
Total Daily Energy Expenditure as measured by doubly labeled water (kcal/day)
54 month
Physical Activity Energy Expenditure
Time Frame: 54 month
Physical Activity Energy Expenditure as measured by doubly labeled water (kcal/day)
54 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Seth A Creasy, PhD, University of Colorado, Denver

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 7, 2019

Primary Completion (Estimated)

January 1, 2024

Study Completion (Estimated)

January 1, 2024

Study Registration Dates

First Submitted

January 29, 2019

First Submitted That Met QC Criteria

February 13, 2019

First Posted (Actual)

February 15, 2019

Study Record Updates

Last Update Posted (Actual)

August 21, 2023

Last Update Submitted That Met QC Criteria

August 15, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 18-1319
  • K01HL145023 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

3
Subscribe